MUMBAI, India, June 24 -- Intellectual Property India has published a patent application (202647068719 A) filed by Boost Biopharma, Inc. on June 01, 2026, for Flavivirus Vaccine Composition.
Inventors include Rancour, David M.; Schomburg, Fritz M.; and Gold, Steven K. Number.
The application for the patent was published on June 12, 2026, under issue no. 24/2026.
Abstract: Provided is a composition comprising at least two independent recombinant polypeptides, each comprising an N-terminal end, a C-terminal end, and at least one immunogenic fragment, wherein each immunogenic fragment consists of an envelope protein domain III of a first Flavivirus type, or an immunogenic portion thereof, wherein at least two of the at least two independent recombinant polypeptides are bound together by a covalent bond; and at least two independent recombinant polypeptides, each comprising an N-terminal end, a C-terminal end, and at least one immunogenic fragment, wherein each immunogenic fragment consists of an envelope protein domain III of a second Flavivirus type, or an immunogenic portion thereof, wherein at least two of the at least two independent recombinant polypeptides are bound together by a covalent bond; and wherein each Flavivirus type is a different type, pharmaceutical compositions containing the same, and methods of making and using the same.
Disclaimer: Curated by HT Syndication.
